Evidence map›Paper›PMID 42515150›Full record

ArticleToxics2026

Animal-Free Skin Sensitization Testing: In Chemico and In Silico Integrated Approach.

Gabriella Lisboa Dos Santos, Gabriela de Oliveira Prado Corrêa, Franciane de Oliveira Cortez, Tugstênio Souza, Bruna Bosquetti, João Antonio Dassie Felippi, Gabriela Trindade de Souza E Silva, Pamela Ferreira do Nascimento, Marcio Adriano Andréo, Marcelo Dutra Duque and 3 more

Abstract read
In one paragraph

Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gabriella Lisboa Dos SantosDepartment of Pharmaceutical Sciences, Federal University of São Paulo, Diadema Campus, Diadema 09913-030, Brazil.ORCID 0000-0001-6984-375X
Gabriela de Oliveira Prado CorrêaPre-Clinical & Product Safety-Grupo Boticário, R. Alfredo Pinto, 2258-Parque da Fonte, São José dos Pinhais 83050-320, Brazil.ORCID 0000-0003-1786-4756
Franciane de Oliveira CortezPre-Clinical & Product Safety-Grupo Boticário, R. Alfredo Pinto, 2258-Parque da Fonte, São José dos Pinhais 83050-320, Brazil.
Tugstênio SouzaPre-Clinical & Product Safety-Grupo Boticário, R. Alfredo Pinto, 2258-Parque da Fonte, São José dos Pinhais 83050-320, Brazil.
Bruna BosquettiPre-Clinical & Product Safety-Grupo Boticário, R. Alfredo Pinto, 2258-Parque da Fonte, São José dos Pinhais 83050-320, Brazil.ORCID 0009-0001-4974-8832
João Antonio Dassie FelippiDepartment of Pharmaceutical Sciences, Federal University of São Paulo, Diadema Campus, Diadema 09913-030, Brazil.
Gabriela Trindade de Souza E SilvaFaculdade de Ciências Farmacêuticas, State University of Campinas, Rua Cândido Portinari, 200, Cidade Universitária Zeferino Vaz, Campinas 13083-871, Brazil.ORCID 0000-0002-1170-9678
Pamela Ferreira do NascimentoDepartment of Pharmaceutical Sciences, Federal University of São Paulo, Diadema Campus, Diadema 09913-030, Brazil.ORCID 0000-0002-7507-8393
Marcio Adriano AndréoDepartment of Pharmaceutical Sciences, Federal University of São Paulo, Diadema Campus, Diadema 09913-030, Brazil.ORCID 0000-0001-6372-3677
Marcelo Dutra DuqueDepartment of Pharmaceutical Sciences, Federal University of São Paulo, Diadema Campus, Diadema 09913-030, Brazil.ORCID 0000-0002-4080-9862
Carolina Motter CatarinoPre-Clinical & Product Safety-Grupo Boticário, R. Alfredo Pinto, 2258-Parque da Fonte, São José dos Pinhais 83050-320, Brazil.
Andrezza di Pietro Micali CanavezPre-Clinical & Product Safety-Grupo Boticário, R. Alfredo Pinto, 2258-Parque da Fonte, São José dos Pinhais 83050-320, Brazil.
Patricia Santos LopesDepartment of Pharmaceutical Sciences, Federal University of São Paulo, Diadema Campus, Diadema 09913-030, Brazil.ORCID 0000-0003-1353-9825

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prohibition of animal testing for cosmetic products has driven the development of alternative approaches to ensure consumer safety. Skin sensitization is one of the most critical toxicological endpoints to evaluate, requiring rigorous assessment to ensure the safety of cosmetic ingredients. This study proposes an Integrated Testing Strategy (ITS) that combines in chemico (Direct Peptide Reactivity Assay-DPRA) and in silico approaches (a six-platform computational panel) to evaluate the sensitization potential of substances. Initially, the in chemico methodology was validated through a partial proficiency demonstration to ensure experimental reliability. Subsequently, this ITS was applied to the

Indexed as

Baccharis trimeraDPRAin chemicoin silicosafety testingskin barrierskin sensitization

Identifiers

PMID42515150
PMCPMC13416716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.